Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratin 5 Antikörper (AA 316-590)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Cytokeratin 5 in IHC und StM. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN6939864

Kurzübersicht für Cytokeratin 5 Antikörper (AA 316-590) (ABIN6939864)

Target

Alle Cytokeratin 5 (KRT5) Antikörper anzeigen
Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

Reaktivität

  • 147
  • 85
  • 57
  • 12
  • 11
  • 11
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 108
  • 53
  • 2
Maus

Klonalität

  • 93
  • 70
Monoklonal

Konjugat

  • 73
  • 17
  • 12
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Cytokeratin 5 Antikörper ist unkonjugiert

Applikation

  • 102
  • 76
  • 47
  • 32
  • 30
  • 27
  • 18
  • 14
  • 13
  • 13
  • 10
  • 9
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
Immunohistochemistry (IHC), Staining Methods (StM)

Klon

KRT5-3594
  • Bindungsspezifität

    • 16
    • 16
    • 15
    • 11
    • 9
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 316-590

    Spezifität

    This MAb recognizes a protein of 58 kDa, which is identified as Cytokeratin 5 (KRT5). This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Antibodies to KRT5 identify basal cells of squamous and glandular epithelia, myoepithelia, and mesothelium.Anti-cytokeratin 5 has been reported useful in the differential diagnosis of metastatic carcinoma in the pleura versus epithelioid mesothelioma. Almost all squamous cell carcinomas, half of transitional carcinomas, and many undifferentiated large cell carcinomas express.Anti-KRT5, along with anti-p63, affords a high sensitivity and specificity for squamous differentiation. Myoepithelial cells of the breast, glandular epithelia, and basal cells of the prostate are labeled with anti-KRT5.

    Aufreinigung

    Purified by Protein A/G

    Immunogen

    Recombinant fragment (around aa 316-590) of human Cytokeratin 5 (KRT5) protein (exact sequence is proprietary)

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Positive Control: MCF-7 or HeLa cells. Human tonsil, esophagus or bladder tissue (IHC).

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

    Andere Bezeichnung

    KRT5

    Molekulargewicht

    58kDa

    Gen-ID

    3852

    UniProt

    P13647
Sie sind hier:
Chat with us!